248 related articles for article (PubMed ID: 7729473)
21. In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Snyder C; Chollet J; Santo-Tomas J; Scheurer C; Wittlin S
Exp Parasitol; 2007 Mar; 115(3):296-300. PubMed ID: 17087929
[TBL] [Abstract][Full Text] [Related]
22. Biguanide-atovaquone synergy against Plasmodium falciparum in vitro.
Jones K; Ward SA
Antimicrob Agents Chemother; 2002 Aug; 46(8):2700-3. PubMed ID: 12121961
[TBL] [Abstract][Full Text] [Related]
23. Plasmodium falciparum: the effects of atovaquone resistance on respiration.
Suswam E; Kyle D; Lang-Unnasch N
Exp Parasitol; 2001 Aug; 98(4):180-7. PubMed ID: 11560411
[TBL] [Abstract][Full Text] [Related]
24. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro.
Mariga ST; Gil JP; Wernsdorfer WH; Björkman A
Acta Trop; 2005 Mar; 93(3):221-31. PubMed ID: 15725382
[TBL] [Abstract][Full Text] [Related]
27. Direct comparison of antimalarial activity among PS-15 combination therapies by bioassay of serum samples from treated Saimiri sciureus.
Yeo AE
J Parasitol; 1997 Jun; 83(3):515-8. PubMed ID: 9194836
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of artemisone compared with artesunate against Plasmodium falciparum.
Ramharter M; Burkhardt D; Nemeth J; Adegnika AA; Kremsner PG
Am J Trop Med Hyg; 2006 Oct; 75(4):637-9. PubMed ID: 17038685
[TBL] [Abstract][Full Text] [Related]
29. In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum.
Gupta S; Thapar MM; Wernsdorfer WH; Björkman A
Antimicrob Agents Chemother; 2002 May; 46(5):1510-5. PubMed ID: 11959589
[TBL] [Abstract][Full Text] [Related]
30. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
van Vugt M; Leonardi E; Phaipun L; Slight T; Thway KL; McGready R; Brockman A; Villegas L; Looareesuwan S; White NJ; Nosten F
Clin Infect Dis; 2002 Dec; 35(12):1498-504. PubMed ID: 12471569
[TBL] [Abstract][Full Text] [Related]
31. Atovaquone/proguanil resistance in Africa: a case report.
David KP; Alifrangis M; Salanti A; Vestergaard LS; Rønn A; Bygbjerg IB
Scand J Infect Dis; 2003; 35(11-12):897-8. PubMed ID: 14723376
[TBL] [Abstract][Full Text] [Related]
32. Mode of action and mechanisms of resistance for antimalarial drugs.
Olliaro P
Pharmacol Ther; 2001 Feb; 89(2):207-19. PubMed ID: 11316521
[TBL] [Abstract][Full Text] [Related]
33. Atovaquone-proguanil resistance in imported falciparum malaria in a young child.
Rose GW; Suh KN; Kain KC; Le Saux N; McCarthy AE
Pediatr Infect Dis J; 2008 Jun; 27(6):567-9. PubMed ID: 18434932
[TBL] [Abstract][Full Text] [Related]
34. [Experience with the combination atovaquone-proguanil in the treatment of uncomplicated Plasmodium falciparum malaria--report of 112 cases].
Malvy D; Djossou F; Vatan R; Pistone T; Etienne G; Longy-Boursier M; Le Bras M
Med Trop (Mars); 2002; 62(3):229-31. PubMed ID: 12244916
[TBL] [Abstract][Full Text] [Related]
35. Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.
Prescrire Int; 2008 Apr; 17(94):54-6. PubMed ID: 18516806
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of the in vitro sensitivity of Plasmodium falciparum to artemisinin in two border areas of Thailand.
Woitsch B; Wernsdorfer G; Prajakwong S; Rojanawatsirivet C; Kollaritsch H; Wernsdorfer WH
Wien Klin Wochenschr; 2004; 116 Suppl 4():35-40. PubMed ID: 15683041
[TBL] [Abstract][Full Text] [Related]
37. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
[TBL] [Abstract][Full Text] [Related]
38. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
Schwartz E; Bujanover S; Kain KC
Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
[TBL] [Abstract][Full Text] [Related]
39.
Liu R; Li G; Li M; Wang B; Zhang D; Xu L; Zhao L; Liao R; Xu Q; Bei Z-C; Song Y
Microbiol Spectr; 2024 Jul; 12(7):e0063024. PubMed ID: 38780257
[TBL] [Abstract][Full Text] [Related]
40. Atovaquone-proguanil for prophylaxis and treatment of malaria.
Marra F; Salzman JR; Ensom MH
Ann Pharmacother; 2003 Sep; 37(9):1266-75. PubMed ID: 12921511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
